Enabling affordable access to actionable health data at home, through easy, accurate urine and saliva tests.
Bisu has raised $550K in total funding. The most recent round was Convertible Note. The last funding was announced in November 2022.
Bisu's investors include SOSV, 15th Rock, ASICS Ventures Corporation, SOSV HAX, QUAD Investment Management.
Bisu is headquartered in Tokyo, Japan.
Enabling affordable access to actionable health data at home, through easy, accurate urine and saliva tests.
Bisu is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bisu — Funding & Investors." VCBacked, November 11, 2022, https://www.vcbacked.co/company/bisu-tokyo. Accessed October 22, 2026.
VCBacked. (2022). Bisu — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/bisu-tokyo
{{cite web |title=Bisu — Funding & Investors |url=https://www.vcbacked.co/company/bisu-tokyo |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated